BALYASNY ASSET MANAGEMENT L.P. - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 210 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2023$8,344,880
+25.0%
254,650
+34.2%
0.02%
+13.3%
Q2 2023$6,677,478
-56.5%
189,755
-59.6%
0.02%
-60.5%
Q1 2023$15,336,456
+291.1%
469,723
+359.2%
0.04%
+137.5%
Q3 2021$3,921,000102,2920.02%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$496,847,00095.45%
Vivo Capital, LLC 3,400,261$150,598,00016.63%
Nan Fung Group Holdings Ltd 510,978$22,631,00014.44%
venBio Partners LLC 1,125,673$49,856,00011.54%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$11,715,0003.76%
ASHFORD CAPITAL MANAGEMENT INC 490,768$21,736,0003.32%
NEUMEIER POMA INVESTMENT COUNSEL LLC 636,485$28,190,0002.79%
Octagon Capital Advisors LP 243,500$10,785,0001.86%
TANG CAPITAL MANAGEMENT LLC 310,000$13,730,0001.68%
Lisanti Capital Growth, LLC 248,070$10,987,0001.47%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders